Seer Bio Partners with Enlight Medical to Commercialize the Proteograph™ Product Suite in ChinaGlobeNewsWire • 08/12/21
Biodesix Announces Presentation on Novel Proteomic Techniques in Partnership with SeerBusiness Wire • 06/17/21
Seer, Inc. (SEER) CEO Omid Farokhzad on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/11/21
Seer's (SEER) CEO Omid Farokhzad on Q4 and Full Year 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/30/21
Seer and SCIEX Sign Commercial Agreement to Offer End-to-End Unbiased Proteomics SolutionsGlobeNewsWire • 03/29/21
Seer Reports Fourth Quarter and Full Year 2020 Financial Results and Fuels Commercial Progress in 2021 with New Collaborators and PartnershipsGlobeNewsWire • 03/29/21
Seer to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021GlobeNewsWire • 03/01/21
Seer Signs Commercial Agreement to Provide Complete End-to-End Solution for Unbiased, Deep, Rapid and Large-Scale ProteomicsGlobeNewsWire • 01/11/21
Seer Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 12/08/20
U.S. IPO Weekly Recap: The IPO Market Is Taught A Thing Or Two In An 8 IPO WeekSeeking Alpha • 12/07/20